Targeted protein degradation technology: proprietary drugs are not difficult, drug resistance is no longer
The anticancer drug Lenalidomide was once one of the world's top-selling small molecule drugs and orphan drugs, with sales of up to 9.978 billion US dollars in 2022, and its development company Celgene made huge profits.
危险品化学品经营许可证（带存储）